Article Title
Access to Medicine in Developing Countries: Elevating State Obligations Over Corporate Profit
Document Type
Article
Publication Date
2-15-2022
Publication Citation
29 Indiana J. Global Legal Studies 131 (2022)
Abstract
This paper investigates the divergence between the objectives of the state in ensuring citizens' right to health and the profit-maximization objective of pharmaceutical corporations in relation to, access to, and supply of medicine. This divergence is pertinent given both the rising cost of medicines and unmet needs, particularly in developing countries. This paper analyses the correlation between pharmaceutical corporations' profit drive and the state's welfare obligation. There is a need to bridge the gap between business and human rights, which can be achieved by combining the concepts of "business ethical responsibility" and corporations' contributions to "common good" with the jurisprudence on the right to health. This is imperative in view of the impact of the business of pharmaceutical corporations on vulnerable populations, particularly in, but not limited to, developing countries.
Recommended Citation
Yusuf, Hakeem O. and Omoteso, Kamil
(2022)
"Access to Medicine in Developing Countries: Elevating State Obligations Over Corporate Profit,"
Indiana Journal of Global Legal Studies: Vol. 29:
Iss.
1, Article 4.
Available at:
https://www.repository.law.indiana.edu/ijgls/vol29/iss1/4
Included in
Business Organizations Law Commons, Comparative and Foreign Law Commons, Human Rights Law Commons, International Law Commons, Jurisprudence Commons